Skip to main content
. Author manuscript; available in PMC: 2023 Jun 11.
Published in final edited form as: J Card Fail. 2022 Apr 22;28(7):1149–1157. doi: 10.1016/j.cardfail.2022.03.354

Table 2.

Recipient and Donor Characteristics of Transplanted Women, Stratified by Allocation System

Variable Women in the Old Allocation System (n = 1483) Women in the New Allocation System (n = 1503) P Value
Recipient characteristics
 Age (y), mean 51.4 ± 13.7 50.6 ± 13.5 .094
 BMI, mean 27.0 ± 5.3 27.3 ± 5.5 .094
Status at transplant* <.001
 Status 1A 753 (50.8%)
 Status 1B 401 (27.0%)
 Status 2 (old) 58 (3.9%)
 Status 1 8 (0.5%) 114 (7.5%)
 Status 2 68 (4.6%) 610 (40.6%)
 Status 3 68 (4.6%) 282 (18.8%)
 Status 4 99 (6.7%) 381 (25.3%)
 Status 5 3 (0.2%) 15 (1.9%)
 Status 6 23 (1.6%) 99 (6.6%)
Ventricular support
 Inotrope 606 (41.5%) 600 (40.2%) .489
Temporary MCS
 IABP 132 (9.0%) 405 (27.1%) <.001
 ECMO 23 (1.6%) 82 (5.5%) <.001
 Durable LVAD 465 (31.8%) 319 (21.8%) <.001
Donor
 Donor age (y) 32.5 ± 11.5 31.9 ± 10.6 .058
 Female donor sex 938 (63.3%) 910 (60.5%) .012
 White donor race 944 (64.7%) 942 (63.1%) .586
Ischemic time (h) 3.14 ± 1.10 3.40 ± 1.02 <.001
Distance traveled (miles) 187.50 ± 207.0 272.84 ± 233.7 <.001
*

Patients with status 1–6 were listed in the old allocation system but transplanted in the new allocation system.

HCV, hepatitis C virus. Other abbreviations as in Table 1.